Naringin abrogates angiotensin-converting enzyme (ACE) activity and?podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension.

Oyagbemi AA, Ajibade TO, Esan OO, Adetona MO, Obisesan AD, Adeogun AV, Awoyomi OV, Badejo JA, Adedapo ADA, Omobowale TO, Olaleye OI, Ola-Davies OE, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Yakubu MA, Nwulia E, Oguntibeju OO. Naringin abrogates angiotensin-converting enzyme (ACE) activity and?podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension. Biomarkers. 2023 Mar; 28(2):206-216.

View in: PubMed

subject areas

Angiotensins
Animals
Antioxidants
Cobalt
Hypertension
Male
Mammals
Rats
Rats, Wistar

authors with profiles

Momoh Yakubu

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support